Concert Pharmaceuticals (CNCE) Soars: Stock Rises 25.8%

Loading...
Loading...
Concert Pharmaceuticals, Inc. CNCE was a big mover last session, as the company saw its shares rise nearly 26% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $8.47 to $10.06 in the past one-month time frame.

Though the company has seen no negative revisions in the past 30 days, its Zacks Consensus Estimate moved lower over the same time frame, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday's jump lasts.

Concert Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

However, better-ranked stocks in the med-drugs industry inlcude Hyperion Therapeutics, Inc. HPTX, Lannett Company, Inc. LCI and Akebia Therapeutics, Inc. AKBA. While Hyperion Therapeutics and Lannett Company sport a Zacks Rank #1 (Strong Buy), Akebia Therapeutics has a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free report


CONCERT PHARMA CNCE: Free Stock Analysis Report

HYPERION THERAP HPTX: Free Stock Analysis Report

LANNETT INC LCI: Free Stock Analysis Report

AKEBIA THERAP AKBA: Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research
Loading...
Loading...
Posted In: Movers & ShakersGeneral
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...